PAVmed Inc. (PAVM)

[MaineMan5]

Risk / reward here is greatly outsized in favor of reward with their two lead products addressing $1+ billion markets each, plus their other potential products. Devices are easier to get approved than drugs and their two lead devices offer excellent improvements to existing products and each addresses a large market. With recent funding completed and company saying funds in hand will get them through commercialization for both products, positive rulings here could mean big things for SP. Recently hired Chief Commercial Officer to bring products to market which indicates company is confident in approval (otherwise they would have waited the 30-60 days and hired him after approval, but they want to start getting this to market ASAP - and if you were taking that position, wouldn't you want some type of confidence from the company that they would have something for you to market shortly?). Low float and they communicate well with shareholders. A positive outcome for these two devices (second one isn't scheduled until 1st Q 2019) would, I think, propel the SP significantly.